Breaking barriers to access for cancer patients
Official title: Understanding and Breaking Barriers to Research Access for Cancer Patients
Run by The Clatterbridge Cancer Centre NHS Foundation Trust · NCT07342335 · Data updated 2026-11-12
This project will try ways to make it easier for adults with cancer treated at Clatterbridge to join clinical research, focusing on people from minority ethnic backgrounds, lower-income groups, and those with impaired capacity.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | The Clatterbridge Cancer Centre NHS Foundation Trust Academic / other |
| Locations | 1 site (Liverpool) |
| Status | Recruiting |
| Started | November 29, 2024 |
| Main results expected | May 31, 2026 |
| Study ends | November 30, 2026 |
| Registry record updated | April 15, 2026 |
| Trial ID | NCT07342335 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with a confirmed cancer diagnosis who are planned to receive or are receiving treatment at The Clatterbridge Cancer Centre and who can give informed consent are eligible.
✕Probably not a fit
People under 18, those not treated at Clatterbridge, or patients with severe co-morbidities that prevent consent or completion of study requirements are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational programme will collect information on who currently takes part in research across the Clatterbridge Cancer Centre network and where gaps in participation exist. Teams will use routine data, patient surveys, and stakeholder interviews to identify socio-economic and geographic hotspots of under‑representation. Work will focus on practical barriers to consent and participation within the hub-and-spoke service model serving Cheshire and Merseyside. Findings will be used to design targeted approaches to increase equitable access to clinical research opportunities.
Why it matters
Potential benefit: If successful, more patients from under‑represented groups could access research opportunities, improving fairness and the relevance of cancer studies to the whole population.
How similar studies have gone: Previous efforts using community outreach, tailored consent processes, and data-driven targeting have shown some success in improving representation but challenges remain and context-specific work is often needed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults over 18 years. No upper age limit * A confirmed diagnosis of cancer * Patient planned to or is receiving treatment at The Clatterbridge Cancer Centre NHS Foundation Trust * Able to provide informed consent Exclusion Criteria: * Patients with severe co-morbidities considered by the screening team to interfere with the individual's ability to complete requirements of the study or to provide informed consent.
Where it's running
-
Clatterbridge Cancer Centre
Liverpool, United Kingdom Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Urine samples from adults with solid cancers to explore chemistry linked to nearing end of life
This study tests urine chemistry in adults with solid tumors to see if it reflects how close a patient is to death.
-
Brain MRI surveillance for HER2-positive metastatic breast cancer
This study tests whether adding regular brain MRIs helps detect hidden brain involvement earlier in people with HER2-positive metastatic breast cancer.
-
Real-world data and samples from frail or multiply treated large B‑cell lymphoma patients
This project collects health records and blood and tissue samples from older, frail, or multiply treated people with diffuse large B‑cell lymphoma to see which treatments they receive and how they fare.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.